Latest Biologic Stories
-- Data presented at the National Kidney Foundation (NKF) Spring Meeting; single and multiple-dose pharmacokinetic and pharmacodynamic (PK/PD) studies support biosimilar application for Epoetin Hospira
Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 LONDON, March 26, 2015 /PRNewswire/ -- SummaryRheumatoid arthritis (RA) is a chronic
LONDON, March 26, 2015 /PRNewswire/ -- SummaryRheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints.
Legislation would lower out-of-pocket drug costs for Americans with chronic diseases PORTLAND, Ore., March 26, 2015 /PRNewswire-USNewswire/ -- Americans with chronic diseases like
With FDA's Approval of the First Biosimilar in the U.S., Groups Urge OMB to Work with FDA to Finalize Critical Naming Policy Supporting Patient Safety WASHINGTON, March 26, 2015 /PRNewswire-USNewswire/
YONGIN, South Korea, March 26, 2014 /PRNewswire/ -- Green Cross, a South Korean biopharmaceutical company, and Nanolek, a Russian pharmaceutical company, today announced that they have entered
PORTLAND, Oregon, March 25, 2015 /PRNewswire/ -- Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types,
According to the new report from BCC Research, the global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a
Timely survey released as FDA approves first biosimilar WASHINGTON, March 23, 2015 /PRNewswire/ -- The Alliance for Safe
In a March 31 webinar, three veteran pharmacy observers will detail steps payers can take now to develop effective biosimilars management strategies. Washington,
- One who brings meat to the table; hence, in some countries, the official title of the grand master or steward of the king's or a nobleman's household.